triamcinolone

(redirected from Nasacort hfa)
Also found in: Thesaurus, Medical, Encyclopedia.

tri·am·cin·o·lone

 (trī′ăm-sĭn′ə-lōn′)
n.
A synthetic glucocorticoid, C21H27FO6, used, usually in acetal or acetate forms, in the treatment of a wide variety of inflammatory and allergic conditions.

[Perhaps from tri- + am(yl) + cin(ene), a terpene (cin(eole) + -ene) + (prednis)olone.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

triamcinolone

(ˌtraɪæmˈsɪnəˌləʊn)
n
(Pharmacology) pharmacol an anti-inflammatory drug used in the treatment of respiratory and allergic conditions
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

tri•am•cin•o•lone

(ˌtraɪ æmˈsɪn əˌloʊn)

n.
a synthetic glucocorticoid drug, C21H27FO6, used in the symptomatic treatment of inflammation.
[1955–60; triamcin- (of undetermined derivation) + (prednis) olone]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.triamcinolone - a synthetic corticosteroid (trade names Aristocort or Aristopak or Kenalog) used as an anti-inflammatory agenttriamcinolone - a synthetic corticosteroid (trade names Aristocort or Aristopak or Kenalog) used as an anti-inflammatory agent
adrenal cortical steroid, corticoid, corticosteroid - a steroid hormone produced by the adrenal cortex or synthesized; administered as drugs they reduce swelling and decrease the body's immune response; "adrenal cortical steroids are used to treat many different conditions"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

triamcinolone

n triamcinolona
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
has licensed rights to develop and market Nasacort HFA, a nasal allergy treatment, from Sanofi U.S., Acton reported yesterday.
The Food and Drug Administration approved Nasacort HFA but the product never went on the market because of manufacturing issues, Acton reported.
Nasacort HFA Nasal Aerosol (triamcinolone acetonide, Aventis Pharmaceuticals)